Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AD-209 [Phase 3]

View source ↗

Summary

Phase III study evaluating the efficacy and safety of AD-209 for essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AD-209

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypertension,Essential | Phase 3 | Status: RECRUITING